Article

FFB funds nearly $3 million to research

Almost $3 million has been invested in nine research projects aimed at saving and restoring sight by the Foundation Fight Blindness.

 

Columbia, MD-Almost $3 million has been invested in nine research projects aimed at saving and restoring sight by the Foundation Fighting Blindness.

The foundation’s Scientific Advisory Board completed its annual grants review process, leading to the allocation of seven new $300,000, three-year grants which total $2.1 million.

The grants will focus on developing cross-cutting gene therapies, identifying new disease-causing gene mutations, and advancing potential treatments for dry age-related macular degeration.

Another $800,000 was awarded to two research efforts at the University of California, Berkley, which focus on optogenetic approaches to treat blinding inherited retinal diseases.

“Retinal diseases together affect more than 10 million Americans, and with an aging population, this number is growing,” said Stephen Rose, PhD, the foundation’s chief research officer. “The progress being made in research right now is remarkable; however, there is still a long way to go to secure the resources to significantly expand the portfolio of trials across the spectrum of retinal diseases.”

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.